Y. Vanrenterghem, C. Ponticelli, and J. M. Morales, Prevalence and management of anemia in renal transplant recipients: A European survey, Am J Transplant, vol.3, pp.835-845, 2003.

N. Kamar, L. Rostaing, S. Ignace, and E. Villar, Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: A meta-analysis, Clin Transplant, vol.26, pp.461-469, 2012.

V. Garrigue, I. Szwarc, and M. Giral, Influence of anemia on patient and graft survival after renal transplantation: Results from the French DIVAT cohort, Transplantation, vol.97, pp.168-175, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02163407

P. I. Terasaki, Humoral theory of transplantation, Am J Transplant, vol.3, pp.665-673, 2003.

M. Karpinski, D. Pochinco, I. Dembinski, W. Laidlaw, J. Zacharias et al., Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates, J Am Soc Nephrol, vol.15, pp.818-824, 2004.

J. C. Scornik, Leukoreduced blood and sensitization of organ transplant candidates, Transfusion, vol.52, pp.1838-1839, 2012.

G. S. Balasubramaniam, M. Morris, A. Gupta, I. R. Mesa, R. Thuraisingham et al., Allosensitization rate of male patients awaiting first kidney grafts after leuko-depleted blood transfusion, Transplantation, vol.93, pp.418-422, 2012.

B. A. Magee, J. Martin, M. P. Cole, K. G. Morris, and A. E. Courtney, Effects of HLA-matched blood transfusion for patients awaiting renal transplantation, Transplantation, vol.94, pp.1111-1116, 2012.

C. Lefaucheur, A. Loupy, and G. S. Hill, Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation, J Am Soc Nephrol, vol.21, pp.1398-1406, 2010.

J. C. Scornik, J. D. Schold, M. Bucci, and M. Hu, Effects of blood transfusions given after renal transplantation, Transplantation, vol.87, pp.1381-1386, 2009.

S. Fidler, R. Swaminathan, and W. Lim, Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss, Transpl Immunol, vol.29, issue.1-4, pp.22-27, 2013.

A. Favardeh and M. Eickhoff, Frequency of blood transfusion episodes after kidney transplantation is associated with development of Class II Donor Specific Antibodies (abstract)

, Am J Transplant, vol.13, issue.5, p.194, 2013.

J. C. Scornik and M. Hu, Blood transfusions in organ transplant patients: Mechanisms of sensitization and implications for prevention, Am J Transplant, vol.11, pp.1785-1791, 2011.

E. V. Billen, M. H. Christiaans, J. Lee, and E. M. Van-den-berg-loonen, Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay, Transplantation, vol.87, pp.563-569, 2009.

J. C. Scornik and H. U. Kriesche, Human leukocyte antigen sensitization after transplant loss: Timing of antibody detection and implications for prevention, Hum Immunol, vol.72, pp.398-401, 2011.

D. Bello, A. , C. , N. Sallusto, and F. , Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy, Clin J Am Soc Nephrol, vol.7, pp.1310-1319, 2012.

J. D. Pirsch, J. Miller, M. H. Deierhoi, F. Vincenti, and R. S. Filo, A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group, Transplantation, vol.63, pp.977-983, 1997.

A. Webster, R. C. Woodroffe, R. S. Taylor, J. R. Chapman, and J. C. Craig, Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients, Cochrane Database Syst Rev, p.3961, 2005.

H. Ekberg, H. Tedesco-silva, and A. Demirbas, Reduced exposure to calcineurin inhibitors in renal transplantation, N Engl J Med, vol.357, pp.2562-2575, 2007.

N. Kamar, D. Bello, A. , C. , and N. , Incidence of donor-specific antibodies in kidney transplant patients following conversion to an everolimus-based calcineurin inhibitor-free regimen, Clin Transplant, vol.27, pp.455-462, 2013.

L. Liefeldt, S. Brakemeier, and P. Glander, Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation, Am J Transplant, vol.12, pp.1192-1198, 2012.

L. Rostaing, A. Hertig, and L. Albano, Fibrosis progression according to epithelial-mesenchymal transition profile: A randomized trial of everolimus versus CsA, Am J Transplant, vol.15, pp.1303-1312, 2015.

M. El-ters, J. P. Grande, and M. T. Keddis, Kidney allograft survival after acute rejection, the value of follow-up biopsies, Am J Transplant, vol.13, pp.2334-2341, 2013.

J. M. Chemouny, C. Suberbielle, and M. Rabant, De novo donorspecific human leukocyte antigen antibodies in nonsensitized kidney transplant recipients after T cell-mediated rejection, Transplantation, vol.99, pp.965-972, 2015.